In Europe, between 1 and 2 years. I spoke to my psychiatrist yesterday and he told me that in Argentina it will be at the end of 2025.
3 Likes
Reddit - Dive into anything Another new testimony
1 Like
how do you know for sure in europe 1-2years its a few i guess
1 Like
Only Bristol Myers knows the exact date.
The rest is all estimates. After the United States, Europe always comes first for the sale of a drug. Then Japan, China. First always the large markets with the greatest purchasing power.
1 Like
Reddit - Dive into anything Another new testimony. But this testimony has not started taking the medication yet, he complains about the insurance. He says that the doctor prescribed Cobenfy but apparently the insurance does not want to cover the cost.
Anyone know how to obtain it? The drug store said you can’t pick it up there.
1 Like
That one review somewhere above really makes me feel positive about Cobenfy. Like it’ll make a difference, no sleepiness and no weight gain is MASSIVE positives
2 Likes
I’m not a medical professional. It sounds a little like a red pill to me.
1 Like
He also says that he enjoys socializing, which he didn’t before. And that makes sense, no one enjoys socializing with current antipsychotics, at least most of them.
3 Likes
Sounds so promising man, I’m excited 
2 Likes
great if you catch any news for cobenfy and europe pls share
1 Like
thats its soo true
1 Like
I searched and found an article but in Spanish. I can’t paste it here because it’s in Spanish and the moderators don’t allow it. It says that at the end of 2025 in Europe.
The website is ‘‘elglobalfarma’’, search on your own or else I’ll see if I can send you the link by private message, I don’t know if it’s allowed. I should ask a moderator.
2 Likes
I will translate into English what the article says.
"As for the commercialization of Cobenfy, Bristol Myers Squibb has been clear in its roadmap. The company expects the drug to be available in the US market by the end of October 2024, at which time the Cobenfy Cares support program, designed to help patients who receive the prescription of the drug, will also be launched. This timeline indicates that the company has prioritized a rapid market entry following FDA approval.
On the other hand, the arrival of Cobenfy in Europe will require approval from the European Medicines Agency (EMA). This process is usually longer and can take between 12 and 18 months from the submission of the marketing authorization application. If Bristol Myers Squibb is already preparing the necessary documentation, it is reasonable to expect Cobenfy to reach the European market between late 2025 and early 2026.
Although some European countries with accelerated approval systems could see its availability sooner, widespread adoption across the European Union could take longer due to price and reimbursement negotiations with national health systems. This means that while the treatment will be available relatively soon in the United States, full access in Europe could take longer."
2 Likes
sent the link if you want
1 Like
I sent you the link by private message.
1 Like
4 Likes
Dam, I could work as an Actuary if it could give me a boost in cognition. Cognition is where I am suffering…and people are saying it is like Adderall, it is definitely something I would go on with my eyes closed. Better than the APs I take.
3 Likes
I am beginning to believe that this antipsychotic is much better than the current ones. But there are still some more testimonies needed to confirm this.
5 Likes
https://www.reddit.com/r/schizophrenia/comments/1gw2gnk/step_by_step_on_how_i_got_cobenfy_for_cheap/
Another new testimony
1 Like